Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor α blockade in patients with rheumatoid arthritis

Arthritis and Rheumatism

Volumn 43, Issue 1, 2000, Pages 38-47

  Taylor, Peter C ^a   Michael Peters, A ^b   Paleolog, Ewa ^a   Chapman, Peter T ^a   Elliott, Michael J ^a   McCloskey, Richard ^c   Feldmann, Marc ^a   Maini, Ravinder N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; INDIUM 111; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; METHOTREXATE; MONOCYTE CHEMOTACTIC PROTEIN 1; PREDNISOLONE; RANTES; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

ANTIGEN PRESENTING CELL; ARTICLE; CELL MIGRATION; CLINICAL TRIAL; CYTOKINE RELEASE; DRUG EFFICACY; DRUG MECHANISM; GRANULOCYTE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOTHERAPY; ISOTOPE LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL;

AGED; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD22; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ARTHRITIS, RHEUMATOID; B-LYMPHOCYTES; CELL ADHESION MOLECULES; CELL MOVEMENT; CHEMOKINE CCL2; CHEMOKINES; CHEMOKINES, CXC; CHEMOTACTIC FACTORS; FEMALE; GROWTH SUBSTANCES; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INDIUM RADIOISOTOPES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTERLEUKIN-8; JOINTS; LECTINS; LEUKOCYTES; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MIDDLE AGED; NEUTROPHILS; RANTES; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0343674489     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200001)43:1<38::AID-ANR6>3.0.CO;2-L     Document Type: Article

References (44)

1. Elliott MJ, Maini RN, Feldmann M, Long-Fox A, Charles P, Katsikis P, et al. Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α. Arthritis Rheum 1993;36:1681-90.
2. Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, et al. Randomised double blind comparison of a chimaeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet 1994;344:1105-10.
3. Moreland LW, Baumgartner SW, Schiff MH, Tindall EA, Fleischmann RM, Weaver AL, et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997;337:141-7.
4. Maini RN, Breedveld FC, Kalden JR, Smolen JS, Davis D, Macfarlane JD, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor α monoclonal antibody with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998;41:1552-63.
5. Feldmann M, Brennan FM, Maini RN. Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996;14:397-440.
6. Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell 1996;85:307-10.
7. Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M. Inhibitory effect of TNF α antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989;2:244-7.
8. Williams RO, Feldmann M, Maini RN. Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 1992;89:9784-8.
9. Tak PP, Taylor PC, Breedveld FC, Smeets TJM, Daha MR, Kluin PM, et al. Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor a monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1077-81.
10. Taylor PC, Maini RN, Tak PP, Breedveld FC, Smeets TJM, Daha MR, et al. Reply [letter]. Arthritis Rheum 1997;40:789-90.
11. Gearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993;14:506-12.
12. Paleolog EM, Hunt M, Elliott MJ, Feldmann M, Maini RN, Woody JN. Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor α antibody in rheumatoid arthritis. Arthritis Rheum 1996;39:1082-91.
13. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
14. Doherty MR, Richards N, Hornby J, Powell R, Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy. Ann Rheum Dis 1988;47:190-7.
15. Peters AM, Saverymuttu SH, Reavy HJ, Danpure HJ, Osman S, Lavender JP. Imaging of inflammation with indium-111 tropolonate labelled leukocytes. J Nucl Med 1983;24:39-44.
16. Saverymuttu SH, Peters AM, Reavy HJ, Lavender JP. Measurement of granulocyte migration and accumulation in inflammation in man. Clin Exp Immunol 1983;52:607-12.
17. Paulus HE, Egger MJ, Ward JR, Williams HJ, and the Cooperative Systematic Studies of Rheumatic Disease Group. Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying antirheumatic drugs, based on the findings in patients treated with placebo. Arthritis Rheum 1990;33:477-84.
18. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
19. Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK, et al. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 1992;90:772-9.
20. Koch AE, Kunkel SL, Shah MR, Hosaka S, Halloran MM, Haines GK, et al. Growth-related gene product α: a chemotactic cytokine for neutrophils in rheumatoid arthritis. J Immunol 1995;155: 3660-6.
21. Chapman PT, Haskard DO. Leukocyte adhesion molecules. Br Med Bull 1995;51:296-311.
22. Carlos TM, Harlan JM. Leukocyte-endothelial adhesion molecules. Blood 1994;84:2068-101.
23. Smart SJ, Casale TB. TNFα-induced transendothelial neutrophil migration is IL-8 dependent. Am J Physiol 1994;266:L238-45.
24. Brennan FM, Zachariae CO, Chantry D, Larsen CG, Turner M, Maini RN, et al. Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells. Eur J Immunol 1990;20:2141-4.
25. Huber AR, Kunkel SL, Todd RF, Weiss SJ. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991;254:99-102.
26. Roberts PJ, Pizzey AR, Khwaja A, Carver JE, Mire-Sluis AR, Linch DC. The effects of IL-1 on neutrophil f-Met-Leu-Phe receptors, CD11b expression and metabolic activity, in comparison and combination with other cytokines. Br J Haematol 1993;84: 586-94.
27. Butler DM, Maini RN, Feldmann M, Brennan FM. Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures: comparison of monoclonal anti-TNFα antibody with the IL-1 receptor antagonist. Eur Cytokine Netw 1995;6:225-30.
28. Taylor PC, Peters AM, Glass DM, Maini RN. Effect of treatment of rheumatoid patients with anti-TNFα on reticuloendothelial and intrapulmonary granulocyte traffic. Clin Sci 1999;97:85-9.
29. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med 1989;320:365-76.
30. Bromley M, Woolley DE. Histopathology of the rheumatoid lesion: identification of cell types at sites of cartilage erosion. Arthritis Rheum 1984;27:857-63.
31. Mohr W, Wessinghage D. The relationship between polymorphonuclear granulocytes and cartilage destruction in rheumatoid arthritis. J Rheumatol 1978;37:81-96.
32. Mohr W, Westerhellweg H, Wessinghage D. Polymorphonuclear granulocytes in rheumatic tissue destruction. III. An electron microscopic study of PMNs at the cartilage-pannus junction in rheumatoid arthritis. Ann Rheum Dis 1981;40:396-9.
33. Mohr W, Wild A, Wolf HP. Role of polymorphs in inflammatory cartilage destruction in adjuvant arthritis in rats. Ann Rheum Dis 1981;40:171-6.
34. Jasin HE. Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1985;28:241-8.
35. Jasin HE, Cooke TD. The inflammatory role of immune complexes trapped in joint collagenous tissues. Clin Exp Immunol 1978;33:416-24.
36. Ugai K, Ishikawa H, Hirohata K, Shirane H. Interaction of polymorphonuclear leukocytes with immune complexes trapped in rheumatoid articular cartilage. Arthritis Rheum 1983;26:1434-41.
37. Ugai K, Ziff M, Jasin HE. Interaction of polymorphonuclear leukocytes with immune complexes trapped in joint collagenous tissues. Arthritis Rheum 1979;22:353-64.
38. Hasty KA, Hibbs MS, Kang AH, Mainardi CL. Secreted forms of human neutrophil collagenase. J Biol Chem 1986;261:5645-50.
39. Marcartney HW, Tschesche H. Latent and active human polymorphonuclear leucocyte collagenases: isolation, purification and characterisation. Eur J Biochem 1983;130:71-8.
40. Chatham WW, Blackburn WD Jr, Heck LW. Additive enhancement of neutrophil collagenase activity by HOCI and cathepsin G. Biochem Biophys Res Commun 1992;184:560-7.
41. Sorsa T, Konttinen YT, Lindy O, Ritchlin C, Saari H, Suomalainen K, et al. Collagenase in synovitis of rheumatoid arthritis. Semin Arthritis Rheum 1992;22:44-53.
42. Weiss SJ, Klein R, Slivka A, Wei M. Chlorination of taurine by human neutrophils: evidence of hypochlorous acid generation. J Clin Invest 1982;70:598-607.
43. Weiss SJ, Peppin G, Ortiz X, Ragsdale C, Test ST. Oxidative autoactivation of latent collagenase by human neutrophils. Science 1985;227:747-9.
44. Brennan FM, Browne KA, Green PA, Jasper J-M, Maini RN, Feldmann M. Reduction of serum matrix metalloproteinase 1 and matrix-metalloproteinase 3 in RA patients following anti-TNFα (cA2) therapy. Br J Rheumatol 1997;36:643-50.